SYRE Equity Ratio

Spyre Therapeutics Inc · Equity Ratio

SYRE logo

SYRE Equity Ratio

Current (TTM)93.87%
SYRE Equity Ratio (69.28% → 93.87%)
High-resolution chart · PNG

SYRE equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
91.9585%
85.0974%
53.828%
70.7087%
76.3614%
86.5201%
72.2275%
86.7364%
89.7641%
93.8908%
93.403%
63.8908%
69.2843%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.